Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Creator and developer of fully-human monoclonal antibody-based products to treat a wide range of diseases.Funding
Funding rounds
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Index Ventures LLP |
+44 (1534) 753-858 |
N/A |